Not Tagged
Not Tagged
[]
congress | #esmo22 | hong cen at guangxi medical university presents data from a study of shrna-mediated pd1 gene knock-down anti-cd19 car-t cell therapy in pts with r/r b-cell malignancies orr was 62.5% and pd was 37.5% with an acceptable safety profile.
#lymphoma #lymsm 
A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia (#CLL) #lymsm